Hiding in Plain Sight: Why Albendazole's Proven Track Record Still Hasn't Reached Most American Medicine Cabinets
Albendazole has demonstrated remarkable clinical effectiveness against a broad spectrum of parasitic infections, yet most Americans have never heard of it. Despite its over-the-counter availability, a convergence of marketing gaps, provider silence, and institutional inertia keeps this well-established medication firmly out of public consciousness. Understanding why that gap exists is the first step toward closing it.